Patent · US Active

Antibodies specific for human complement C5A receptor (C5AR)

US12018072B2 · kind B2 · utility

0Cited by

0References

30Claims

0Family size

Assignee

MORPHOSYS AG · DE

Inventors

Julia Neugebauer · Munich, DE
Barbara Bachler-Konetzki · Hamburg, DE
Tanja Herrmann · Munich, DE
Winfried Elis · Gräfelfing, DE

Key dates

Filing date	Aug 25, 2023
Grant date	Jun 25, 2024
Priority date	—
Expiry date	Aug 25, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides novel antibodies or antibody fragments specifically binding to human C5aR. In particular, it relates to antibodies or antibody fragments that have combined beneficial properties and are therefore useful for the treatment of inflammatory or autoimmune diseases or cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.